Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,858,201
+$1,609,570 QoQ
Shares Held
13,416
+45.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#850
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealthspire Advisors, LLC holds $100,760,753 across 13 Drug Manufacturers - General names. AMGN ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,830 | $33,380,139 | |
| 2 | JNJ |
Johnson & Johnson
|
101,693 | $25,826,971 | |
| 3 | ABBV |
AbbVie Inc.
|
67,367 | $16,952,231 | |
| 4 | MRK |
Merck & Co., Inc.
|
75,165 | $9,658,702 | |
| 5 | AMGN |
Amgen Inc
This page
|
13,416 | $4,858,201 | |
| 6 | PFE |
Pfizer Inc
|
141,769 | $3,413,797 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
40,673 | $2,343,578 | |
| 8 | AZN |
Astrazeneca PLC
|
6,632 | $1,257,559 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,858,201 | 13,416 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,248,631 | 9,233 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,848,183 | 11,757 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,144,437 | 7,599 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,293,989 | 8,216 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,563,433 | 8,228 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,173,998 | 8,341 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $2,793,238 | 8,669 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,626,767 | 8,407 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,419,563 | 8,510 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,568,274 | 8,917 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,448,941 | 9,112 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $840,567 | 3,786 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,016,800 | 4,206 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,579,254 | 6,013 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $914,447 | 4,057 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,063,950 | 4,373 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $640,823 | 2,650 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,316,749 | 5,853 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,086,641 | 5,110 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $449,718 | 1,845 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,591,604 | 10,416 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,769,924 | 7,698 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,222,255 | 4,809 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,059,011 | 4,490 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,632,246 | 12,984 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||